See the companies making headlines in premarket trading. Oracle — Information technology shares rose 13.3% on strong earnings per share. Oracle posted adjusted earnings per share of $1.41, which exceeded the $1.38 consensus estimate of analysts surveyed by LSEG. About Holding: Shares fell more than 14% after the shoemaker announced quarterly results that disappointed investors. In the fourth quarter, On Holding reported a loss of CHF0.05), lower than expected earnings per share of CHF0.10, according to StreetAccount's consensus estimate. Revenue of CHF447.1 million fell short of the consensus estimate of CHF450.9 million. Kohl's — Shares rose 2.2% after the retailer reported rising fourth-quarter earnings and sales. Earnings per share came in at $1.67, beating the consensus estimate of $1.28 per LSEG. Revenue was $5.71 billion, versus the expected $5.7 billion. The company also announced it will add Babies R Us to approximately 200 stores this fall. Asana – The work management platform fell 2.3% after weak full-year revenue guidance. Asana said it expected between $716 million and $722 million, missing the $725 million forecast from analysts surveyed by LSEG. That diverted attention from the better-than-expected fourth-quarter earnings report. Coinbase – Shares rose 2.1% after Raymond James said he was less pessimistic about the crypto trading platform. The company raised stock-to-market performance from underperform, citing the impact of exchange-traded funds on inflows. Southwest Airlines – The airline's stock price fell 7% after Southwest Airlines said it was “reevaluating all previous guidance for full-year 2024, including the expectation for capital expenditures” due to delays in aircraft deliveries from Boeing. The airline expects unit revenue to remain flat and rise no more than 2% from a year earlier, lower than its January estimate that expects an increase of as much as 4.5%. Southwest also said leisure bookings were weaker than expected in the first quarter. Bitdeer Technologies – The crypto stock rose by 4.6% after the introduction of B. Riley with a buy rating. The company said Bitdeer is well positioned because of its diverse business model and access to cheap energy. Ventyx – The biopharmaceutical shares rose 7.1% after Wall Street found reasons to approve the latest clinical update. Wells Fargo upgraded the stock to overweight, while raising its price target for shares to $16. Meanwhile, Oppenheimer upgraded its rating to outperform and raised its price target to $12 per share. Microstrategy – The bitcoin developer rose 6.2% on bullish commentary from Wall Street analysts. Canaccord Genuity, which has a buy rating, said the stock is not “resting on its laurels” as bitcoin soars to record highs and raised its price target to $1,810. TD Cowen also raised its price target to $1,560 while maintaining its outperform rating, noting the rapid rise to incremental bitcoin holdings. – CNBC's Sarah Min, Lisa Kailai Han and Michelle Fox contributed reporting